HSPG2 and acute myeloid leukemia: Kaplan–Meier survival analysis manifested that OS and LFS of patients with high HSPG2 expression were significantly shorter than those of patients with low HSPG2 expression in the whole cohort of AML patients (P < 0.001, Fig. 4a; P = 0.047, Fig. 4d).